The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs
Abstract
Purpose: To describe treatment patterns among patients with central or branch retinal vein occlusion (CRVO or BRVO) in France, Germany, and Italy, and to estimate retinal vein occlusion (RVO)-related direct medical costs. Methods: We used a retrospective chart review to determine 18-month RVO-related resource utilization and calculate 12-month health care costs. Country-specific unit costs (€) were assigned to each resource from the perspective of the health care payer. Costs for France and Germany were based on 2005, and for Italy on 2007 values. Results: Data from a total of 109 BRVO and 119 patients with CRVO were used in the analysis. Laser therapy was the most commonly used intervention in Germany, for both CRVO and patients with BRVO (95%-98% of treatments), while patients in France with either condition had triamcinolone injections most often (63%-67% of treatments). Injections were also administered frequently in Italy and were the most common treatment for CRVO (50%), whereas patients with BRVO used laser therapy most often (41%). Inpatient treatment was most common in Germany (42% of CRVO and 34% of patients with BRVO), and did not occur at all in Italy except for day admissions. Total costs were higher for patients with CRVO in all countries. Most costs in Italy and France were attributable to outpatient treatment. In Germany, hospitalization made up the largest proportion of costs (80%), although more patients used outpatient services. Conclusions: Approaches to treating BRVO and CRVO vary across European countries. Development of agreed-upon guidelines would support consistency in patient care and reimbursement policy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the multi-country study reported direct medical costs by RVO type, which ranged from $1,361 to $3,395 per patient per annum for branch RVO and from $2,078 to $4,774 per patient per annum for central RVO (Fig. 8.a and Supplementary Table 9).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [60]
In the citing paper
“Three studies analysed costs associated with macular oedema secondary to RVO [57, 60] and mCNV [61] (see Fig. 8 and Supplementary Table 9).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [60]
In the citing paper
“For RVO, direct medical costs were estimated at $9,018 [57] in Spain, and ranged from $1,785 to $4,085 across Germany, France and Italy in the multi-country analysis [60] (Supplementary Table 9).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [60]
Citations
Cites
Natural History and Clinical Management of Central Retinal Vein Occlusion
(1997) · Archives of Ophthalmology · doi:10.1001/archopht.1997.01100150488006 · Cited by 663
Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion
Clarkson, J. G., Chuang, E., Gass, D., Pedroso, M., Cubillas, T., Duria, E. S., Hess, D. J., Rams, I., Ball, M., Gutierrez, A., et al. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30849-4 · Cited by 508
The 15-Year Cumulative Incidence of Retinal Vein Occlusion: The Beaver Dam Eye Study
Klein, R. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.4.513 · Cited by 404 · cited 1×
“Baseline medication 1 (3) 9 (24) — 1 (4) 2 (12) —”
Clarkson, J. G., Chuang, E., GASS, D. J. M., et al. (1995) · PubMed · Cited by 336
(1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30848-2 · Cited by 334
Ten-Year Incidence of Retinal Vein Occlusion in an Older Population: The Blue Mountains Eye Study
Cugati, S. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.5.726 · Cited by 321 · cited 3×
“To our knowledge, the epidemiology of RVO in Europe has not been reported, but a long-term study of Australians aged at least 49 years at baseline by Cugati et al (3) reported a 10-year incidence of 1.2% for branch RVO (BRVO) and 0.4% for central RVO (CRVO).”
ResultInfluentialInterventions for Central Retinal Vein Occlusion
Mohamed, Q., McIntosh, R. L., Saw, S. M., & Wong, T. Y. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.11.011 · Cited by 206 · cited 2×
“No other options have been well-studied in either BRVO or CRVO and no standard RVO treatment has been recognized (7-9).”
BackgroundInterventions for Branch Retinal Vein Occlusion
McIntosh, R. L., Mohamed, Q. A., Saw, S., & Wong, T. Y. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.01.010 · Cited by 132 · cited 3×
“Medication 62 (128) 35 (63) 2 (8) 20 (35) 8 (19) 7 (27)”
BackgroundManagement of Retinal Vein Occlusion – Consensus Document
COSCAS, G. J., Loewenstein, A., Augustin, A. J., Bandello, F. M., Parodi, M. B., Lanzetta, P., Monés, J., de Smet, M. D., Soubrane, G., & Staurenghi, G. (2011) · Ophthalmologica · doi:10.1159/000327391 · Cited by 123 · cited 1×
“Based on the best available scientific advice, a collaborative group of European retina specialists have recently put forward practical recommendations for the clinical approach to RVO (18).”
BackgroundSelf-citationPegaptanib Sodium for Macular Edema Secondary to Central Retinal Vein Occlusion
Wroblewski, J. J. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.14 · Cited by 104
Research works printed but not linked: 3
- Chen J.C., 1995, Can J Ophthalmol, 30, 21
- Journal Officiel de la République Française (2006). Available at: http://textes.droit.org/JORF/2006/03/23/0070/. Accessed June 2009.
- Gewaily D., 2009, Cochrane Database Syst Rev, 1, CD007324
Cited by
Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis
Li, J. Q., Terheyden, J. H., Welchowski, T., Schmid, M. C., Letow, J., Wolpers, A. C., Holz, F. G., & Finger, R. P. (2018) · Ophthalmologica · doi:10.1159/000494224 · Cited by 31
Özkaya, A. (2016) · Beyoglu Eye Journal · doi:10.14744/bej.65375 · Cited by 7
Özkaya, A. (2017) · Beyoglu Eye Journal · doi:10.14744/bej.2017.13007 · Cited by 2
A decade of early benefit assessment of ophthalmic drugs in Germany: success story or not?
Dintsios, C. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1930532 · Cited by 2
Grassi, M. O., Russo, A., Vadalà, M., Allmeier, H., Machewitz, T., Varano, M., & on behalf of the AURIGA Study Investigators (2025) · Ophthalmologica · doi:10.1159/000545534 · Cited by 2
“In addition, many clinicians in Italy initiate treatment with laser therapy [26], even though anti-VEGF therapies are widely considered the gold standard in RVO treatment [7].”
Metadata
- Authors
- Augustin, A. J., Sahel, J.-A., Cerulli, L., Texier-Richard, B., Buchholz, P. M., & Kobelt, G.
- Affiliations
- Städtisches Klinikum Karlsruhe (DE)
- INSERM, U968, Paris - France
- University of Rome Tor Vergata (IT)
- European Health Economics SAS, Spéracèdes - France
- Allergan (Germany) (DE)
- European Health Economics SAS, Mulhouse - France
- Corresponding author
- Augustin, Albert J.
- Venue
- European Journal of Ophthalmology
- Publisher
- SAGE Publications
- Published
- 2012-09
- Volume
- 22
- Issue
- 5
- Pages
- 776-784
- ISSN
- 1120-6721 (ISSN-L)
- 1724-6016
- OpenAlex
- W2084220761
- Cited by
- 7
- References
- 19
- Citations by year
- 2025: 1 · 2021: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- European Journal of Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Keywords
- retinal vein occlusion, central retinal vein occlusion, branch retinal vein occlusion, treatment patterns, health care costs, resource utilization (health care), laser therapy, triamcinolone injection, hospitalization, outpatient care, cross-national comparison, France, Germany, Italy
- MeSH terms
- Aged, Female, France, Germany, Glucocorticoids, Health Resources, Health Services Research, Humans, Inpatients, Italy, Macular Edema, Male, Middle Aged, Outpatients, Practice Patterns, Physicians', Retinal Vein Occlusion, Retrospective Studies, Triamcinolone Acetonide, Visual Acuity, Health Care Costs, Laser Coagulation, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs. https://app.cochat.ai/papers/10.5301/ejo.5000180
- The paper
- Augustin, A. J., Sahel, J.-A., Cerulli, L., Texier-Richard, B., Buchholz, P. M., & Kobelt, G. (2012). Treating retinal vein occlusions in France, Germany, and Italy: an analysis of treatment patterns, resource consumption, and costs. European Journal of Ophthalmology. https://doi.org/10.5301/ejo.5000180
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.